Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > did not like
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(139)
•••
Comment by Tapps21on Jun 30, 2021 7:03pm
328 Views
Post# 33477741

RE:RE:RE:RE:did not like

RE:RE:RE:RE:did not likeThere were many issues not addressed and It appeared long term  data was not available to provide concrete guidance moving forward. The "mess up" at the beginning of P2 is evident that it has played a part in this.

P2 paitents with the optimized treatment will be telling as to what the company really has to offer the "Cancer" world. Fingers crossed

Money and funding was not addressed....should it have?

I still believe a certain percentage of CR should be evident before you can apply for patents of such bold staements. Cancer is devastating to familes and individuals all over the world and I would never want to be given false hope or be mislead.

Then again, we are only at .255 cents and I'm sure the SP will/would be much higher when/if TLD1433 shows promising results. 

Keeping the faith...

BT
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities